Optimization boosts extracellular mpt64 protein yield in E. coli, suggesting advancement in TB diagnostic tools.
Tuberculosis (TB) remains a global health burden, requiring affordable and scalable diagnostic tools. The MPT64 protein is a secreted biomarker specific to Mycobacterium tuberculosis and holds promise for rapid antigen-based diagnostics. However, existing recombinant expression systems often yield low extracellular amounts, complicating purification and limiting downstream application. This study aimed to optimize the extracellular, tag-free expression of MPT64 protein in Escherichia coli by employing the pelB signal peptide in combination with Response Surface Methodology (RSM). A Box-Behnken design was used to analyze the interactive effects of rhamnose concentration, induction timing, and medium composition. The optimal condition (4 mM rhamnose, 2-h induction, and 1.8-fold medium enrichment) yielded 0.0293 mg/mL of extracellular MPT64. The identity and antigenicity of the secreted protein were validated using Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) and lateral flow immunoassay (LFIA), respectively. This study demonstrates that fine-tuning expression parameters can significantly enhance extracellular protein yield, providing a cost-effective production strategy for MPT64-based TB diagnostics and laying the foundation for future scalable diagnostic development.
No takes yet. Share an insight, caveat, or question.
Kusuma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: